Applicant, as named in the Orange Book
Bausch
Bausch Health Companies Inc · NYSE: BHC
Company and ticker: cliffwatch mapping, checked against SEC EDGAR · SEC filings
Next listed expiry: Acanya on 5 Aug 2029. 9 products with live protection, 46 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Acanya NDA 050819 benzoyl peroxide; clindamycin phosphate | 5 Aug 2029 patent |
| Onexton NDA 050819 benzoyl peroxide; clindamycin phosphate | 5 Aug 2029 patent |
| Zyclara NDA 022483 · 2 strengths imiquimod | 11 Dec 2029 patent, carve-out possible |
| Bryhali NDA 209355 halobetasol propionate | 2 Nov 2031 patent |
| Luzu NDA 204153 luliconazole | 28 Apr 2034 patent |
| Jublia NDA 203567 efinaconazole | 25 Apr 2035 patent |
| Duobrii NDA 209354 halobetasol propionate; tazarotene | 6 Jun 2036 patent |
| Arazlo NDA 211882 tazarotene | 11 May 2038 patent |
| Cabtreo NDA 216632 adapalene; benzoyl peroxide; clindamycin phosphate | 28 Dec 2040 patent |
Recent events
- Jublia · Generic approved · ANDA 212027, AlembicApproved 23 Feb 2026Detected 25 Oct 2026
- Cardizem · Generic approved · ANDA 217633, AlembicApproved 14 Nov 2025Detected 25 Oct 2026
- Metrogel-Vaginal · Generic approved · ANDA 218485, Aurobindo Pharma LtdApproved 25 Sep 2026Detected 25 Oct 2026
- Clindagel · Generic approved · ANDA 218942, Aurobindo Pharma LtdApproved 18 Mar 2026Detected 25 Oct 2026
- Retin-A · Generic approved · ANDA 214590, AlembicApproved 11 Jun 2026Detected 25 Oct 2026
- Retin-A · Generic approved · ANDA 217497, AmnealApproved 14 May 2026Detected 25 Oct 2026
- Cardizem · Generic approved · ANDA 220590, Yichang HumanwellApproved 25 Sep 2026Detected 25 Oct 2026
- Diastat · Generic approved · ANDA 217468, Navinta LlcApproved 14 Nov 2025Detected 25 Oct 2026
- Retin-A · Generic approved · ANDA 217832, EncubeApproved 25 Mar 2026Detected 25 Oct 2026
- Isuprel · Generic approved · ANDA 213305, Deva Holding AsApproved 10 Dec 2025Detected 25 Oct 2026
- Retin-A · Generic approved · ANDA 217833, EncubeApproved 10 Feb 2026Detected 25 Oct 2026
- Mephyton · Generic approved · ANDA 220454, NovaxApproved 26 Feb 2026Detected 25 Oct 2026
- Acanya · Generic approved · ANDA 208757, Actavis Labs Ut IncApproved 7 Aug 2026Detected 25 Oct 2026
- Isuprel · Generic approved · ANDA 220299, AspiroApproved 18 May 2026Detected 25 Oct 2026
- Retin-A · Generic approved · ANDA 218560, Zydus LifesciencesApproved 15 Sep 2026Detected 25 Oct 2026
- Solodyn · Enters 12-month window basis: patent, carve-out possibleListed date 7 Mar 2027Detected 24 Oct 2026
- Solodyn · Enters 12-month window basis: patent, carve-out possibleListed date 7 Mar 2027Detected 24 Oct 2026
- Solodyn · Enters 12-month window basis: patentListed date 2 Apr 2027Detected 24 Oct 2026
- Solodyn · Enters 12-month window basis: patent, carve-out possibleListed date 7 Mar 2027Detected 24 Oct 2026
- Solodyn · Enters 12-month window basis: patent, carve-out possibleListed date 7 Mar 2027Detected 24 Oct 2026
- Solodyn · Enters 12-month window basis: patent, carve-out possibleListed date 7 Mar 2027Detected 24 Oct 2026
Products without listed protection (46)
| Drug | Earliest generic entry |
|---|---|
| Ancobon NDA 017001 · 2 strengths flucytosine | open now no listed protection |
| Aplenzin NDA 022108 · 3 strengths bupropion hydrobromide | open now no listed protection |
| Ativan NDA 017794 · 3 strengths lorazepam | open now no listed protection |
| Cardizem NDA 018602 · 4 strengths diltiazem hydrochloride | open now no listed protection |
| Cardizem Cd NDA 020062 · 5 strengths diltiazem hydrochloride | open now no listed protection |
| Cardizem La NDA 021392 · 6 strengths diltiazem hydrochloride | open now no listed protection |
| Clindagel NDA 050782 clindamycin phosphate | open now no listed protection |
| Demser NDA 017871 metyrosine | open now no listed protection |
| Diastat NDA 020648 diazepam | open now no listed protection |
| Diastat Acudial NDA 020648 · 2 strengths diazepam | open now no listed protection |
| Edecrin NDA 016093 ethacrynate sodium | open now no listed protection |
| Edecrin NDA 016092 ethacrynic acid | open now no listed protection |
| Elidel NDA 021302 pimecrolimus | open now no listed protection |
| Gris-Peg NDA 050475 · 2 strengths griseofulvin, ultramicrosize | open now no listed protection |
| Isordil NDA 012093 · 2 strengths isosorbide dinitrate | open now no listed protection |
| Klaron NDA 019931 sulfacetamide sodium | open now no listed protection |
| Librax NDA 012750 chlordiazepoxide hydrochloride; clidinium bromide | open now no listed protection |
| Locoid NDA 019116 hydrocortisone butyrate | open now no listed protection |
| Locoid NDA 018514 hydrocortisone butyrate | open now no listed protection |
| Mestinon NDA 011665 pyridostigmine bromide | open now no listed protection |
| Mestinon NDA 015193 pyridostigmine bromide | open now no listed protection |
| Mestinon NDA 009829 pyridostigmine bromide | open now no listed protection |
| Mestinon NDA 009830 pyridostigmine bromide | open now no listed protection |
| Migranal NDA 020148 dihydroergotamine mesylate | open now no listed protection |
| Minocin NDA 050649 · 2 strengths minocycline hydrochloride | open now no listed protection |
| Noritate NDA 020743 metronidazole | open now no listed protection |
| Oxsoralen-Ultra NDA 019600 methoxsalen | open now no listed protection |
| Retin-A NDA 017522 tretinoin | open now no listed protection |
| Retin-A NDA 017955 tretinoin | open now no listed protection |
| Retin-A NDA 019049 tretinoin | open now no listed protection |
| Retin-A NDA 017340 tretinoin | open now no listed protection |
| Retin-A Micro NDA 020475 · 2 strengths tretinoin | open now no listed protection |
| Retin-A-Micro NDA 020475 · 2 strengths tretinoin | open now no listed protection |
| Syprine NDA 019194 trientine hydrochloride | open now no listed protection |
| Targretin NDA 021055 bexarotene | open now no listed protection |
| Targretin NDA 021056 bexarotene | open now no listed protection |
| Tiazac NDA 020401 · 6 strengths diltiazem hydrochloride | open now no listed protection |
| Vanos NDA 021758 fluocinonide | open now no listed protection |
| Vaseretic NDA 019221 · 2 strengths enalapril maleate; hydrochlorothiazide | open now no listed protection |
| Vasotec NDA 018998 · 4 strengths enalapril maleate | open now no listed protection |
| Wellbutrin Xl NDA 021515 · 2 strengths bupropion hydrochloride | open now no listed protection |
| Xenazine NDA 021894 · 2 strengths tetrabenazine | open now no listed protection |
| Xerese NDA 022436 acyclovir; hydrocortisone | open now no listed protection |
| Ziana NDA 050802 clindamycin phosphate; tretinoin | open now no listed protection |
| Zovirax NDA 018604 acyclovir | open now no listed protection |
| Zovirax NDA 021478 acyclovir | open now no listed protection |